11/21/19 11/21/19

Investigational drug for people with treatment-resistant epilepsy

8/13/19 8/13/19

Diazepam Buccal Film Beneficial in Refractory Epilepsy With Seizure Clusters

5/20/19 5/20/19

UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.

4/8/19 4/8/19

A drug to stop a seizure in one breath?

4/5/19 4/5/19

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

3/5/19 3/5/19

ADHD Medication Does Not Increase Seizure Risk

2/4/19 2/4/19

NEW DRUG APPLICATION FOR INVESTIGATIONAL ANTI-EPILEPTIC DRUG (AED)

1/8/19 1/8/19

Exposure to Valproate Risk for Attention-Deficit/Hyperactivity Disorder

10/30/18 10/30/18

Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy

10/2/18 10/2/18

FDA Expands Use of Epilepsy Drug Perampanel (Fycompa) to Younger Children

9/27/18 9/27/18

Epilepsy drug (Gabapentin/Neuronton) linked to opioid misuse

9/25/18 9/25/18

Newer epilepsy drugs fail to improve outcomes

8/22/18 8/22/18

FDA Approves Stiripentol for Dravet Syndrome Seizures

8/13/18 8/13/18

FDA To Consider Midazolam Nasal Spray for Acute Cluster Seizure Treatment

5/14/18 5/14/18

UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients

5/10/18 5/10/18

FDA Reports a Life-Threatening Immune Reaction to Lamotrigine: What You Should Know

4/9/18 4/9/18

Antiepileptic drugs linked with an increased risk of Alzheimer’s and dementia, says research

3/27/18 3/27/18

Educational Attainment Down With In Utero Exposure to AEDs

2/12/18 2/12/18

Medication Adherence Key to Epilepsy Treatment

2/12/18 2/12/18

Which commonly prescribed drug is more effective for infants with epilepsy?